Medically reviewed by Jordana Haber Hazan, MD Ludwig angina occurs when a bacterial infection in your teeth or jaw causes ...

Angina is typically a symptom of an underlying heart problem (such as coronary artery disease), which develops when one or more of the heart's arteries become narrowed or blocked. Eleven million ...

The heart condition angina costs the NHS almost £700 million a year, but the 'social' cost could push the figure even higher, a new study has revealed. The cost is more than one per cent of the ...

CAD symptoms include stable angina, reviewed here, and acute coronary syndromes (ACS), reviewed in the Unstable Angina/Non-STEMI Topic Review and STEMI Topic Review. CAD also frequently leads to ...

Objective: To assess the clinical efficacy, safety and effects on quality of life of trimetazidine modified release (MR) in patients with stable angina. Methods: This large, open-label ...

The acute coronary syndromes include unstable angina, non-ST segment elevation myocardial infarction and ST segment elevation myocardial infarction. The terms “transmural,” “non-transmural ...

Calcium antagonists are used in the treatment of hypertension and angina. In the mid-1990s there was considerable debate concerning the safety of calcium antagonists in the treatment of ...

Considering taking supplements to treat unstable angina? Below is a list of common natural remedies used to treat or reduce the symptoms of unstable angina. Follow the links to read common uses ...

Considering taking supplements to treat vasospastic angina? Below is a list of common natural remedies used to treat or reduce the symptoms of vasospastic angina. Follow the links to read common ...

Finding the cause of angina in patients without obstructed coronaries can reassure patients and lead to tailored therapy.

Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost effectiveness of adding a newer anti-anginal drug (nicorandil, ivabradine or ranolazine) to a calcium ...

Shenzhen Salubris Pharmaceuticals Co. Ltd. has disclosed relaxin receptor 1 (RXFP1; LGR7) agonists reported to be useful for the treatment of angina pectoris, acute kidney injury, chronic kidney ...